Pricing of oral generic cancer medicines in 25 European countries; findings and implications



Godman, Brian ORCID: 0000-0001-6539-6972, Hill, Andrew, Simoens, Professor Steven, Kurdi, Amanj, Gulbinovic, Jolanta, Martin, Antony P ORCID: 0000-0003-4383-6038, Timoney, Angela, Gotham, Dzintars, Wale, Janet, Bochenek, Tomasz
et al (show 38 more authors) (2019) Pricing of oral generic cancer medicines in 25 European countries; findings and implications. GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 8 (2). pp. 49-70.

[img] Text
Accepted publication Godman et al.docx - Author Accepted Manuscript

Download (343kB)
Item Type: Article
Uncontrolled Keywords: Cancer, Europe, generic drug regulations, generics, health policy, pricing
Depositing User: Symplectic Admin
Date Deposited: 25 Mar 2019 12:54
Last Modified: 19 Jan 2023 00:56
DOI: 10.5639/gabij.2019.0802.007
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3034697